William J Quinn, a director at $PR, sold 800,000 shares of the company on 03-11-2026 for an estimated $15,321,840. We received data on the trade from a recent SEC filing. This was a sale of approximately 9.7% of their shares of this class of stock. Following this trade, they now own 7,426,839 shares of this class of $PR stock.
$PR Insider Trading Activity
$PR insiders have traded $PR stock on the open market 20 times in the past 6 months. Of those trades, 0 have been purchases and 20 have been sales.
Here’s a breakdown of recent trading of $PR stock by insiders over the last 6 months:
- WILLIAM M III HICKEY (Co-Chief Executive Officer) has made 0 purchases and 3 sales selling 1,676,128 shares for an estimated $27,147,052.
- JAMES H WALTER (Co-Chief Executive Officer) has made 0 purchases and 3 sales selling 1,451,128 shares for an estimated $23,011,609.
- WILLIAM J QUINN sold 800,000 shares for an estimated $15,321,840
- JOHN CHARLES BELL (EVP, General Counsel) has made 0 purchases and 5 sales selling 339,161 shares for an estimated $5,406,266.
- GUY M OLIPHINT (EVP, Chief Financial Officer) has made 0 purchases and 4 sales selling 313,152 shares for an estimated $4,340,667.
- ROBERT REGAN SHANNON (EVP, Chief Accounting Officer) has made 0 purchases and 4 sales selling 185,524 shares for an estimated $2,580,686.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$PR Hedge Fund Activity
We have seen 280 institutional investors add shares of $PR stock to their portfolio, and 332 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BANK OF NEW YORK MELLON CORP added 13,483,136 shares (+115.5%) to their portfolio in Q4 2025, for an estimated $189,168,398
- CITADEL ADVISORS LLC removed 7,775,867 shares (-42.3%) from their portfolio in Q4 2025, for an estimated $109,095,414
- MILLENNIUM MANAGEMENT LLC removed 7,016,014 shares (-71.2%) from their portfolio in Q4 2025, for an estimated $98,434,676
- PRICE T ROWE ASSOCIATES INC /MD/ removed 6,850,832 shares (-19.0%) from their portfolio in Q4 2025, for an estimated $96,117,172
- HOLOCENE ADVISORS, LP added 4,958,161 shares (+inf%) to their portfolio in Q4 2025, for an estimated $69,562,998
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 4,853,683 shares (-55.5%) from their portfolio in Q4 2025, for an estimated $68,097,172
- DIMENSIONAL FUND ADVISORS LP added 4,533,732 shares (+16.7%) to their portfolio in Q4 2025, for an estimated $63,608,259
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$PR Revenue
$PR had revenues of $1.2B in Q4 2025. This is a decrease of -9.78% from the same period in the prior year.
You can track PR financials on Quiver Quantitative's PR stock page.
$PR Analyst Ratings
Wall Street analysts have issued reports on $PR in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Mizuho issued a "Outperform" rating on 12/12/2025
- Piper Sandler issued a "Overweight" rating on 11/18/2025
- Goldman Sachs issued a "Buy" rating on 11/14/2025
- Wells Fargo issued a "Overweight" rating on 10/17/2025
To track analyst ratings and price targets for $PR, check out Quiver Quantitative's $PR forecast page.
$PR Price Targets
Multiple analysts have issued price targets for $PR recently. We have seen 11 analysts offer price targets for $PR in the last 6 months, with a median target of $21.0.
Here are some recent targets:
- Mark Lear from Piper Sandler set a target price of $27.0 on 03/12/2026
- Neil Mehta from Goldman Sachs set a target price of $22.0 on 03/11/2026
- Paul Diamond from Citigroup set a target price of $21.0 on 03/06/2026
- Josh Silverstein from UBS set a target price of $23.0 on 03/05/2026
- Scott Hanold from RBC Capital set a target price of $20.0 on 03/02/2026
- Hanwen Chang from Wells Fargo set a target price of $17.0 on 01/27/2026
- Biju Perincheril from Susquehanna set a target price of $18.0 on 01/26/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
